110 related articles for article (PubMed ID: 38860770)
1. T-cell responses in COVID-19 survivors 6-8 months after infection: A longitudinal cohort study in Pune.
Suryawanshi P; Patil-Takbhate B; Athavale P; Mirza S; Tripathy A; Kanitkar S; Shivnitwar S; Barthwal MS; Dole S; Chavan H; Jali P; Pawale S; Kakad D; Kakrani AL; Bhawalkar J; Gandhi M; Chaturvedi S; Karandikar M; Tripathy S
Immun Inflamm Dis; 2024 Jun; 12(6):e1238. PubMed ID: 38860770
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
[TBL] [Abstract][Full Text] [Related]
3. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
Liu J; Yang X; Wang H; Li Z; Deng H; Liu J; Xiong S; He J; Feng X; Guo C; Wang W; Zelinskyy G; Trilling M; Sutter K; Senff T; Menne C; Timm J; Zhang Y; Deng F; Lu Y; Wu J; Lu M; Yang D; Dittmer U; Wang B; Zheng X
mBio; 2021 Apr; 12(2):. PubMed ID: 33906918
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
[TBL] [Abstract][Full Text] [Related]
7. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India.
Suryawanshi P; Takbhate B; Athavale P; Jali P; Memane N; Mirza S; Karandikar M; Kakrani AL; Kanitkar S; Gandham N; Barthwal MS; Dole S; Chaturvedi S; Pawale S; Tripathy A; Bhawalkar JS; Tripathy S
Viral Immunol; 2023 Apr; 36(3):163-175. PubMed ID: 36897333
[TBL] [Abstract][Full Text] [Related]
8. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
[TBL] [Abstract][Full Text] [Related]
9. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
11. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
[TBL] [Abstract][Full Text] [Related]
12. Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19.
Kumar S; Saxena SK; Maurya VK; Tripathi AK
Front Immunol; 2021; 12():804808. PubMed ID: 35250966
[TBL] [Abstract][Full Text] [Related]
13. Reappearance of effector T cells is associated with recovery from COVID-19.
Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
[TBL] [Abstract][Full Text] [Related]
15. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
Front Immunol; 2021; 12():636768. PubMed ID: 33777028
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC
Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870
[TBL] [Abstract][Full Text] [Related]
17. Functional responsiveness of memory T cells from COVID-19 patients.
Tavukcuoglu E; Horzum U; Cagkan Inkaya A; Unal S; Esendagli G
Cell Immunol; 2021 Jul; 365():104363. PubMed ID: 33905951
[TBL] [Abstract][Full Text] [Related]
18. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
Front Immunol; 2021; 12():751869. PubMed ID: 35003063
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
[TBL] [Abstract][Full Text] [Related]
20. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals.
Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S
J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
